Timolol GFS (Timolol Maleate Ophthalmic) - Summary

TIMOLOL GFS SUMMARY

Timolol GFS
timolol maleate ophthlamic
gel forming solution
0.25% and 0.5%
Sterile

Timolol GFS (timolol maleate ophthalmic gel forming solution) is a non-selective beta-adrenergic receptor blocking agent.

Timolol GFS 0.25% and 0.5% are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

See all Timolol GFS indications & dosage >>

TIMOLOL GFS NEWS HIGHLIGHTS

Published Studies Related to Timolol GFS (Timolol Ophthalmic)

Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. [2008.10]

Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. [2008.04]

Dorzolamide/Timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. [2008.02]

Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy. [2008.02]

Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. [2007.11]

more >>

Clinical Trials Related to Timolol GFS (Timolol Ophthalmic)

24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma [Completed]

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]

Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [Completed]

MK0507A Phase III Double-Blind, Comparative Study [Completed]

Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Completed]

more >>